Bristol-Myers Squibb Co
Here are 3 major moments that drove the stock market last week
A massive market snapback on Friday couldn’t erase all of the week’s damage. After several days of selling, the tech sector roared back, with the Nasdaq gaining over 2% on Friday. Chipmakers Nvidia and Broadcom led the way, with gains of 7.8% and 7.2%, respectively. The broad-based S & P 500 rose nearly 2% in […]
Read More
The White House is launching direct-to-consumer drug site Trump Rx. Here’s what to know
U.S. President Donald Trump makes an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday is slated to announce the launch of TrumpRx – a direct-to-consumer website that is key to his administration’s efforts to lower prescription drug costs […]
Read More
Good news in a sea of pain sends 2 non-tech stocks higher in Thursday’s down market
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. The S & P 500 and Nasdaq were sinking for the third straight session as the rotation out of tech and into the less flashy areas […]
Read More
Stocks making the biggest moves premarket: Qualcomm, Strategy, Align, Estee Lauder and more
Check out the companies making the biggest moves in premarket trading: Qualcomm — The chipmaker sank nearly 11% as a global memory shortage hurt its forecast . Qualcomm expects fiscal second-quarter adjusted earnings of between $2.45 and $2.65 per share on revenue of $10.2 billion to $11 billion. Analysts polled by LSEG were expecting $11.11 […]
Read More
These 4 turnarounds are making headway – plus, updates on our 30 other stocks
Jim Cramer and Jeff Marks, the Club’s director of portfolio analysis, on Thursday delivered updates on all 34 Club holdings during the January Monthly Meeting. Here are the highlights from the first meeting of 2026, starting with our four turnaround stories: 4 turnaround plays Nike: The apparel and sneaker retailer has shown real signs of […]
Read More
Nvidia CEO Jensen Huang says AI won’t be the job killer everyone fears. Here’s why
Nvidia CEO Jensen Huang said Wednesday that artificial intelligence will lead to more jobs, not fewer. In an interview with BlackRock CEO Larry Fink at the World Economic Forum in Davos, Switzerland, Jensen methodically explained how AI differs from other technological innovations of the past and how it can be an incredible engine for economic […]
Read More
CNBC’s UK Exchange newsletter: A diplomacy tightrope for Britain’s Starmer after Trump’s tirades
This report is from this week’s CNBC’s UK Exchange newsletter. Like what you see? You can subscribe here. The dispatch British diplomats have long prided themselves on the so-called “special relationship” with the United States. The phrase was coined by Winston Churchill, Britain’s inspirational wartime leader, when in March 1946 he famously described how an “iron curtain” had descended across […]
Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]
Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]
Read More
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good morning from San Francisco! It’s day three of the annual JPMorgan Healthcare Conference – the biggest gathering of biotech and pharma execs, investors and analysts in […]
Read More